Brian J. Donnelly - 12 Mar 2026 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role
Chief Commerical Officer
Signature
By: Justin Hunter For: Brian J. Donnelly
Issuer symbol
MYGN
Transactions as of
12 Mar 2026
Net transactions value
$0
Form type
4
Filing time
16 Mar 2026, 17:05:46 UTC
Previous filing
01 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Donnelly Brian J Chief Commerical Officer 322 NORTH 2200 WEST, SALT LAKE CITY By: Justin Hunter For: Brian J. Donnelly 16 Mar 2026 0002065630

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYGN Common Stock Award +226,804 +57% $0.000000* 624,338 12 Mar 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of time-based restricted stock units granted pursuant to the Issuer's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date.